Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Cardiología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (PM1116197) LosmApimod To Inhibit p38 MAP Kinase as a TherapeUtic Target and moDify Outcomes After an Acute Coronary syndromE (LATITUDE)-TIMI 60.
INTERVENTIONAL
Inicio: 3 de jun de 2014
ID: NCT02145468
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Safety And Efficacy Study Of Sitaxsentan Sodium In Subjects With Pulmonary Arterial Hypertension
INTERVENTIONAL
Inicio: 1 de dic de 2008
ID: NCT00795639
Completado
Fase 4
ClinicalTrials.gov
A 54 Week, Randomized, Double-blind, Parallel-group, Multicenter Study Evaluating the Long-term Gastrointestinal (GI) Safety and Tolerability of Aliskiren (300 mg) Compared to Ramipril (10 mg) in Patients With Essential Hypertension
INTERVENTIONAL
Inicio: 1 de feb de 2008
ID: NCT00631917
Completado
Fase 3
ClinicalTrials.gov
An International Multicentre Randomized Controlled Trial of Intensive Insulin Therapy Targeting Normoglycemia In Acute Myocardial Infarction: the RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) Pilot Study
INTERVENTIONAL
Inicio: 1 de abr de 2008
ID: NCT00640991
Reclutando
ClinicalTrials.gov
Medtronic Product Surveillance Registry
OBSERVATIONAL
Inicio: 1 de ene de 2012
ID: NCT01524276
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of Efpeglenatide on Cardiovascular Outcomes in Type 2 Diabetes Patients at High Cardiovascular Risk
INTERVENTIONAL
Inicio: 27 de abr de 2018
ID: NCT03496298
Terminado
Fase 1
ClinicalTrials.gov
A Cross-sectional Study of Renal Function in Treatment-naïve, Young Male Patients With Fabry Disease
INTERVENTIONAL
Inicio: 1 de may de 2013
ID: NCT01839526
Desconocido
ClinicalTrials.gov
Prospective, Single Arm, Multi-centre, Observational Registry to Further Validate Safety and Efficacy of the Ultimaster Des System in Unselected Patients Representing Everyday Clinical Practice
OBSERVATIONAL
Inicio: 1 de jun de 2014
ID: NCT02188355
Terminado
Fase 3
ClinicalTrials.gov
A Multicenter, International, Randomized, Active Comparator-controlled, Double-blind, Double-dummy, Parallel-group, 2-arm, Phase 3 Study to Compare the Efficacy and Safety of the Oral FXIa Inhibitor Asundexian (BAY 2433334) With Apixaban for the Prevention of Stroke or Systemic Embolism in Male and Female Participants Aged 18 Years and Older With Atrial Fibrillation at Risk for Stroke
INTERVENTIONAL
Inicio: 5 de dic de 2022
ID: NCT05643573
Completado
Fase 3
ClinicalTrials.gov
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
INTERVENTIONAL
Inicio: 1 de jun de 2006
ID: NCT00358215
Reclutando
Fase 3
ClinicalTrials.gov
A Phase III, Randomised, Double-blind, Placebo-controlled, Event-driven Study to Assess the Efficacy, Safety and Tolerability of Baxdrostat in Combination With Dapagliflozin Compared With Dapagliflozin Alone on Renal Outcomes and Cardiovascular Mortality in Participants With Chronic Kidney Disease and High Blood Pressure
INTERVENTIONAL
Inicio: 3 de mar de 2025
ID: NCT06742723
Completado
Fase 3
ClinicalTrials.gov
ABS-LT: A Phase 3, Long-Term, Open Label, Multicenter Safety Study of Ambrisentan in Subjects With Pulmonary Hypertension
INTERVENTIONAL
Inicio: 17 de nov de 2008
ID: NCT00777920
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
INTERVENTIONAL
Inicio: 30 de ago de 2018
ID: NCT03626688
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
INTERVENTIONAL
Inicio: 25 de ene de 2021
ID: NCT04576988
Terminado
Fase 3
ClinicalTrials.gov
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
INTERVENTIONAL
Inicio: 23 de mar de 2017
ID: NCT03071692
Completado
Fase 3
ClinicalTrials.gov
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™
INTERVENTIONAL
Inicio: 1 de dic de 2001
ID: NCT00600327
Reclutando
Fase 3
ClinicalTrials.gov
ARTEMIS - Effects of Ziltivekimab Versus Placebo on Cardiovascular Outcomes in Patients With Acute Myocardial Infarction
INTERVENTIONAL
Inicio: 25 de jun de 2024
ID: NCT06118281
Completado
ClinicalTrials.gov
Analysis of the Effect of Acidified Omega 3 Esters (DHA+EPA) in Hypertensive Patients With Increased Triglycerides
INTERVENTIONAL
Inicio: 23 de mar de 2023
ID: NCT06840964
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, International Randomized, 2x2 Factorial Design Study to Evaluate the Effects of Lantus (Insulin Glargine) Versus Standard Care, and of Omega-3 Fatty Acids Versus Placebo, in Reducing Cardiovascular Morbidity and Mortality in High Risk People With Impaired Fasting Glucose (IFG), Impaired Glucose Tolerance (IGT) or Early Type 2 Diabetes Mellitus: The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)
INTERVENTIONAL
Inicio: 1 de ago de 2003
ID: NCT00069784
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction (PARAGON-HF)
INTERVENTIONAL
Inicio: 18 de jul de 2014
ID: NCT01920711
Anterior
1
...
35
36
37
...
434
Siguiente
Filtros